Moffitt Cancer Center Receives Two NCI Grants

July 15, 2016

Moffitt Cancer Center researchers recently received two National Cancer Institute (NCI) grants:

Moffitt Cancer Center Awarded $3.2 Million Grant to Study Bone Metastasis in Prostate Cancer
Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis. Prostate cancer frequently spreads to the bone, and can cause painful bony lesion and increased mortality for patients. Their study will integrate molecular, cellular and clinical information into mathematical models to better understand key factors driving the disease to help target when metastasis may occur and identify new therapeutic targets for its prevention.

Moffitt Cancer Center Awarded $3.4 Million Grant to Establish Imaging Biomarker Validation Center
Early detection is one of the most effective strategies to save lives from most cancers.  As part of a new U01 grant awarded to Jae K. Lee, PhD, Robert Gillies, PhD, John Heine, PhD and Matthew Schabath, PhD, the Moffitt Imaging Biomarker Validation Center (MIBVAC) will be established to discover, develop, and validate biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early cancer. Moffitt will also become a Clinical Validation Center for the National Cancer Institute’s Early Detection Research Network.

For more information on these grants, please contact Kim Polacek at or 813-745-7408.